Influenza virus hemagglutinin as a vaccine antigen produced in bacteria.
about
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugsCoated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunity.A novel hemagglutinin protein produced in bacteria protects chickens against H5N1 highly pathogenic avian influenza viruses by inducing H5 subtype-specific neutralizing antibodiesRecent outbreaks of highly pathogenic avian influenza viruses in South Korea.Modulation of Immunogenicity and Conformation of HA1 Subunit of Influenza A Virus H1/N1 Hemagglutinin in Tubular Immunostimulating Complexes.
P2860
Influenza virus hemagglutinin as a vaccine antigen produced in bacteria.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Influenza virus hemagglutinin as a vaccine antigen produced in bacteria.
@ast
Influenza virus hemagglutinin as a vaccine antigen produced in bacteria.
@en
type
label
Influenza virus hemagglutinin as a vaccine antigen produced in bacteria.
@ast
Influenza virus hemagglutinin as a vaccine antigen produced in bacteria.
@en
prefLabel
Influenza virus hemagglutinin as a vaccine antigen produced in bacteria.
@ast
Influenza virus hemagglutinin as a vaccine antigen produced in bacteria.
@en
P1476
Influenza virus hemagglutinin as a vaccine antigen produced in bacteria.
@en
P2093
Violetta Sączyńska
P304
P577
2014-09-08T00:00:00Z